Bruce I Sachs Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Bruce I Sachs is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 45,000 shares of VRTX, which is worth approximately $17.4 Million. The most recent transaction as insider was on Aug 06, 2025, when has been sold 5,000 shares (Common Stock) at a price of $389.6 per share, resulting in proceeds of $1,948,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45K

12.5% 3M change

12.5% 12M change

Total Value Held $17.4 Million

BRUCE I SACHS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 06 2025	BUY Open market or private purchase	$1,948,000 $389.6 p/Share	5,000 Added 10.0%	45,000 Common Stock
Aug 01 2024	SELL Open market or private sale	$2,689,860 $508.0 p/Share	5,295 Reduced 11.69%	40,000 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$665,634 $125.71 p/Share	5,295 Added 10.47%	45,295 Common Stock
May 22 2024	SELL Open market or private sale	$3,168,704 $448.0 p/Share	7,073 Reduced 15.03%	40,000 Common Stock
May 22 2024	BUY Exercise of conversion of derivative security	$661,396 $93.51 p/Share	7,073 Added 13.06%	47,073 Common Stock
Nov 06 2023	SELL Open market or private sale	$4,331,250 $385.0 p/Share	11,250 Reduced 21.95%	40,000 Common Stock
Nov 06 2023	BUY Exercise of conversion of derivative security	$1,434,825 $127.54 p/Share	11,250 Added 18.0%	51,250 Common Stock
Jul 17 2023	SELL Open market or private sale	$4,010,962 $356.53 p/Share	11,250 Reduced 21.95%	40,000 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$1,434,825 $127.54 p/Share	11,250 Added 18.0%	51,250 Common Stock
Apr 13 2023	SELL Bona fide gift	-	1,210 Reduced 2.94%	40,000 Common Stock
Apr 12 2023	SELL Open market or private sale	$6,955,088 $326.53 p/Share	21,300 Reduced 34.07%	41,210 Common Stock
Apr 12 2023	BUY Exercise of conversion of derivative security	$1,536,582 $72.14 p/Share	21,300 Added 25.41%	62,510 Common Stock
Jan 31 2023	SELL Open market or private sale	$390,012 $325.01 p/Share	1,200 Reduced 2.83%	41,210 Common Stock
Jan 31 2023	BUY Exercise of conversion of derivative security	$86,568 $72.14 p/Share	1,200 Added 2.75%	42,410 Common Stock
Aug 02 2021	BUY Open market or private purchase	$2,968,650 $197.91 p/Share	15,000 Added 26.69%	41,210 Common Stock
Nov 10 2020	BUY Open market or private purchase	$3,263,700 $217.58 p/Share	15,000 Added 36.4%	26,210 Common Stock

BIS

Bruce I Sachs

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account